Picture of Elicera Therapeutics AB logo

ELIC Elicera Therapeutics AB Balance Sheet

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Elicera Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.03411.652.443.829.4
Net Total Receivables0.0510.4460.2041.980.784
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.08512.154.245.830.2
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets0.61812.654.746.330.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities0.0042.352.513.513.8
Total Long Term Debt
Total Debt
Total Liabilities0.0042.352.513.513.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity0.61410.252.232.816.4
Total Liabilities & Shareholders' Equity0.61812.654.746.330.2
Total Common Shares Outstanding